Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Subepithelial mucinous corneal dystrophy (SMCD) is a very rare form of superficial corneal dystrophy characterized by frequent recurrent corneal erosions in the first decade of life, with progressive loss of vision.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for subepithelial mucinous corneal dystrophy.
3 publications have been identified in PubMed for subepithelial mucinous corneal dystrophy. Kisho has analyzed 2 by research type. Research spans Review / Meta-Analysis (50%) and Epidemiology / Natural History (50%).
Glegola M (2025). [PMID: 40335960](https://pubmed.ncbi.nlm.nih.gov/40335960/). *BMC Ophthalmol*. [Review / Meta-Analysis]
Touirssa O (2025). [PMID: 40874967](https://pubmed.ncbi.nlm.nih.gov/40874967/). *J Epidemiol Glob Health*. [Epidemiology / Natural History]
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 11:21 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center